(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
![(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept
-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one Structure](CAS/20180528/GIF/1186587-53-0.gif)
- CAS No.
- 1186587-53-0
- Chemical Name:
- (1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
- Synonyms
- Paricalcitol-2;Paricalcitol lmpurity 42;Paricalcitol Impurity AS;(1R,3aR,7aR)-1-((2R,5R,Z)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one;(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one;4H-Inden-4-one, octahydro-1-[(1R,2Z,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-, (1R,3aR,7aR)-;Paricalcitol impurity 2/(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
- CBNumber:
- CB33377063
- Molecular Formula:
- C19H32O2
- Molecular Weight:
- 292.46
- MOL File:
- 1186587-53-0.mol
- Modify Date:
- 2023/6/9 8:28:43
(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one Chemical Properties,Uses,Production
Uses
(1R,3aR,7aR)-Octahydro-1-[(1R,2Z,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-one is a useful synthetic intermediate in the synthesis of 22Z-vitamin D’s. One example is 22Z-Paricalcitol (P195320); the 22Z-isomer of Paricalcitol (P195300) which is a synthetic analog of vitamin D and an antihyperparathyroid.
(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one Preparation Products And Raw materials
(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one Suppliers
Global( 22)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd | 18162595016; 18162595016 | China | 9102 | 58 | Inquiry |
Shenzhen Qingtian Biotechnology Co, Ltd. | 18823167005 18162969855 | China | 2628 | 58 | Inquiry |
Hubei Yangxin Medical Technology Co., Ltd. | 15374522761 | China | 8256 | 55 | Inquiry |
Wuxi Helen Biotechnology Co., Ltd., | 0510-85629785 18013409632 | China | 14081 | 58 | Inquiry |
Nantong Hanfang Biotechnology Co. , Ltd. | 18616537568 | China | 30968 | 58 | Inquiry |
Cato Research Chemicals Inc. | 020-81960175-877 18933936954 | China | 7730 | 58 | Inquiry |
Shanghai Haohong Scientific Co., Ltd. | 400-400-8210725 | China | 39990 | 58 | Inquiry |
Beijing Comparison Pharmaceutical Technology Co., Ltd | 010-010-52878169 15801002657 | China | 4784 | 58 | Inquiry |
Shandong Juntai Pharmaceutical Co., LTD. | 18963498209 | China | 151 | 55 | Inquiry |
1186587-53-0((1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one)Related Search:
2-((3R,5R)-3,5-bis(tert-butyldiMethylsilyloxy)cyclohexylidene)ethanol
2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol
PL-A':(1R,3aR,7aR)-1-((2R,5R,E)-6-hydroxy-5,6-dimethy
lhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
PL-AS':(1R,3aR,7aR)-1-((2R,5R,Z)-6-hydroxy-5,6-dimeth
ylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
benzyl (4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)
carbamate
1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine
(3S,6R,E)-6-((1R,3aS,7aR,E)-4-(2-((3R,5R)-3,5-bis
((tert-butyldimethylsilyl)oxy)cyclohexylidene)
ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-
2,3-dimethylhept-4-en-2-ol
(1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,Z)-6-hydroxy-
5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-
inden-4-ylidene)ethylidene)cyclohexane-1,3-diol
tert-butyl(((1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl
-6-((tetrahydro-2H-pyran-2-yl)oxy)hept-3-en-2-yl)
-7a-methyloctahydro-1H-inden-4-yl)oxy)dimethylsilane
(1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl-6-
((trimethylsilyl)oxy)hept-3-en-2-yl)-7a-
methyloctahydro-4H-inden-4-one
1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)-
chevron_left
1of3
chevron_right
(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept
-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
(1R,3aR,7aR)-1-((2R,5R,Z)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
Paricalcitol-2
Paricalcitol impurity 2/(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
4H-Inden-4-one, octahydro-1-[(1R,2Z,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-, (1R,3aR,7aR)-
Paricalcitol Impurity AS
Paricalcitol lmpurity 42
1186587-53-0